Cargando…
S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428413/ http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46 |
_version_ | 1785090463111315456 |
---|---|
author | Brown, Jennifer R. Desikan, Sai Prasad Nguyen, Bastien Won, Helen Tantawy, Shady Mcneely, Samuel Clark Marella, Narasimha Ebata, Kevin Woyach, Jennifer Patel, Krish Tam, Constantine Eyre, Toby Cheah, Chan Shah, Nirav N Ghia, Paolo Jurczak, Wojciech Balbas, Minna Nair, Binoj Abada, Paolo Wang, Chunxiao Wang, Denise Mato, Anthony R. Gandhi, Varsha Wierda, William G. |
author_facet | Brown, Jennifer R. Desikan, Sai Prasad Nguyen, Bastien Won, Helen Tantawy, Shady Mcneely, Samuel Clark Marella, Narasimha Ebata, Kevin Woyach, Jennifer Patel, Krish Tam, Constantine Eyre, Toby Cheah, Chan Shah, Nirav N Ghia, Paolo Jurczak, Wojciech Balbas, Minna Nair, Binoj Abada, Paolo Wang, Chunxiao Wang, Denise Mato, Anthony R. Gandhi, Varsha Wierda, William G. |
author_sort | Brown, Jennifer R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104284132023-08-17 S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY Brown, Jennifer R. Desikan, Sai Prasad Nguyen, Bastien Won, Helen Tantawy, Shady Mcneely, Samuel Clark Marella, Narasimha Ebata, Kevin Woyach, Jennifer Patel, Krish Tam, Constantine Eyre, Toby Cheah, Chan Shah, Nirav N Ghia, Paolo Jurczak, Wojciech Balbas, Minna Nair, Binoj Abada, Paolo Wang, Chunxiao Wang, Denise Mato, Anthony R. Gandhi, Varsha Wierda, William G. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428413/ http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Oral Sessions Brown, Jennifer R. Desikan, Sai Prasad Nguyen, Bastien Won, Helen Tantawy, Shady Mcneely, Samuel Clark Marella, Narasimha Ebata, Kevin Woyach, Jennifer Patel, Krish Tam, Constantine Eyre, Toby Cheah, Chan Shah, Nirav N Ghia, Paolo Jurczak, Wojciech Balbas, Minna Nair, Binoj Abada, Paolo Wang, Chunxiao Wang, Denise Mato, Anthony R. Gandhi, Varsha Wierda, William G. S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title | S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title_full | S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title_fullStr | S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title_full_unstemmed | S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title_short | S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY |
title_sort | s146: genomic evolution and resistance to pirtobrutinib in covalent btk-inhibitor (cbtki) pre-treated chronic lymphocytic leukemia (cll) patients: results from the phase i/ii bruin study |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428413/ http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46 |
work_keys_str_mv | AT brownjenniferr s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT desikansaiprasad s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT nguyenbastien s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT wonhelen s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT tantawyshady s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT mcneelysamuelclark s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT marellanarasimha s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT ebatakevin s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT woyachjennifer s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT patelkrish s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT tamconstantine s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT eyretoby s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT cheahchan s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT shahniravn s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT ghiapaolo s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT jurczakwojciech s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT balbasminna s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT nairbinoj s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT abadapaolo s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT wangchunxiao s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT wangdenise s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT matoanthonyr s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT gandhivarsha s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy AT wierdawilliamg s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy |